LivaNova PLC (LIVN) Income Statement
LIVN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsLIVN revenue and net income
Where LIVN's revenue goes
2025Each bar shows an amount and its share of revenue. LIVN kept −17.5% of revenue as net income.
LIVN profit margins
LIVN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +10.7% | +10.8% | +8.2% | +16.9% |
| Gross profit | +7.9% | +9.9% | +9.6% | +13.5% |
| Operating income | +54.5% | — | — | +8.4% |
| Net income | −483.5% | — | — | — |
| EPS (diluted) | +11.6% | +16.1% | +24.2% | +5.4% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
LIVN quarterly EPS vs estimates
LivaNova beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 4, 2026 (estimate $0.90).
LIVN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.39B | $1.25B | $1.15B | $1.02B | $1.04B | $934.2M | $1.08B | $1.11B | $1.01B | $1.21B |
| Cost of revenue | $448.2M | $382.6M | $382.3M | $314.6M | $329.4M | $339.5M | $360.4M | $372.5M | $360.7M | $509.5M |
| Gross profit | $939.9M | $870.9M | $771.2M | $707.2M | $706.0M | $594.8M | $723.8M | $734.5M | $651.6M | $704.4M |
| Research & development | $185.8M | $182.5M | $193.8M | $155.8M | $183.4M | $152.9M | $197.1M | $146.0M | $109.7M | $122.5M |
| Sales, general & admin | $548.8M | $526.3M | $504.4M | $469.2M | $471.9M | $427.8M | $506.5M | $462.4M | $382.2M | $357.1M |
| Total operating expenses | $740.5M | $741.8M | $839.7M | $784.0M | $706.8M | $868.7M | $895.4M | $648.2M | $523.4M | $637.2M |
| Operating income | $199.4M | $129.1M | −$68.5M | −$76.8M | −$784,000 | −$273.9M | −$171.6M | −$248.1M | $95.7M | −$27.6M |
| Interest income | $19.0M | $30.1M | $20.1M | $4.7M | $435,000 | $131,000 | $803,000 | $847,000 | $1.3M | $1.7M |
| Interest expense | $49.3M | $63.1M | $58.9M | $48.2M | $50.2M | $40.8M | $15.1M | $9.8M | $7.8M | $10.6M |
| Income before taxes | −$220.8M | $88.3M | −$81.3M | −$75.2M | −$124.6M | −$348.3M | −$127.6M | −$247.4M | $121.1M | −$33.0M |
| Income taxes | $21.6M | $25.1M | −$98.9M | $11.1M | $11.2M | −$960,000 | −$30.4M | −$69.6M | $50.0M | $5.1M |
| Net income | −$242.5M | $63.2M | $17.5M | −$86.2M | −$135.8M | −$348.8M | −$157.6M | −$189.4M | −$25.1M | −$62.8M |
| EBITDA | −$129.5M | $202.5M | $38.5M | $30.9M | −$6.3M | $20.3M | $131.5M | −$167.7M | $199.1M | $121.2M |
| EPS (diluted) | $3.76 | $3.37 | $2.81 | $2.40 | $2.12 | $1.27 | $3.08 | $3.54 | $3.54 | $2.53 |
| Gross margin | 67.7% | 69.5% | 66.9% | 69.2% | 68.2% | 63.7% | 66.8% | 66.4% | 64.4% | 58.0% |
| Operating margin | 14.4% | 10.3% | −5.9% | −7.5% | −0.1% | −29.3% | −15.8% | −22.4% | 9.5% | −2.3% |
| Net margin | −17.5% | 5.0% | 1.5% | −8.4% | −13.1% | −37.3% | −14.5% | −17.1% | −2.5% | −5.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $390.6M | $362.3M | $360.9M | $357.8M | $352.5M | $316.9M | $321.8M | $318.1M | $318.6M | $294.9M | $310.1M | $286.1M |
| Cost of revenue | $116.9M | $117.4M | $121.1M | $112.9M | $113.5M | $96.1M | $102.5M | $92.9M | $103.7M | $87.5M | $120.0M | $84.3M |
| Gross profit | $273.7M | $244.8M | $239.8M | $244.9M | $239.0M | $220.8M | $219.4M | $225.3M | $214.9M | $207.4M | $190.2M | $201.8M |
| Research & development | $53.7M | $49.1M | $52.1M | $48.6M | $47.2M | $37.9M | $43.3M | $48.8M | $44.7M | $45.7M | $46.2M | $46.5M |
| Sales, general & admin | $158.1M | $143.6M | $143.4M | $138.5M | $137.8M | $133.7M | $135.6M | $131.7M | $129.1M | $129.9M | $133.3M | $134.8M |
| Total operating expenses | $224.2M | $192.7M | $197.2M | $190.9M | $184.8M | $172.2M | $182.3M | $189.6M | $174.7M | $191.1M | $278.2M | $197.3M |
| Operating income | $49.5M | $52.2M | $42.6M | $54.0M | $54.2M | $48.6M | $37.0M | $35.6M | $40.2M | $16.2M | −$88.0M | $4.5M |
| Interest income | $3.8M | $3.6M | $4.5M | $3.9M | $4.2M | $6.4M | $8.6M | $7.1M | $7.3M | $7.0M | $6.0M | $5.9M |
| Interest expense | $7.2M | $8.3M | $19.8M | $10.9M | $12.3M | $15.3M | $15.8M | $15.9M | $15.5M | $15.9M | $15.6M | $15.0M |
| Income before taxes | $18.5M | $26.6M | $27.7M | $33.9M | $33.3M | −$315.7M | $56.5M | $44.5M | $21.6M | −$34.2M | −$94.3M | −$2.0M |
| Income taxes | −$90.2M | $4.3M | −$3.2M | $7.1M | $6.2M | $11.7M | $589,000 | $11.5M | $5.2M | $7.7M | −$110.7M | $5.3M |
| Net income | $108.6M | $22.3M | $30.9M | $26.8M | $27.2M | −$327.3M | $55.9M | $33.0M | $16.3M | −$41.9M | $16.3M | −$7.3M |
| EBITDA | $43.9M | $50.5M | $62.1M | $60.0M | $60.6M | −$285.7M | $84.8M | $73.4M | $49.4M | −$5.2M | −$62.8M | $28.1M |
| EPS (diluted) | $1.02 | $0.98 | $0.86 | $0.97 | $1.05 | $0.88 | $0.81 | $0.90 | $0.93 | $0.73 | $0.87 | $0.73 |
| Gross margin | 70.1% | 67.6% | 66.4% | 68.4% | 67.8% | 69.7% | 68.2% | 70.8% | 67.4% | 70.3% | 61.3% | 70.5% |
| Operating margin | 12.7% | 14.4% | 11.8% | 15.1% | 15.4% | 15.3% | 11.5% | 11.2% | 12.6% | 5.5% | −28.4% | 1.6% |
| Net margin | 27.8% | 6.2% | 8.6% | 7.5% | 7.7% | −103.3% | 17.4% | 10.4% | 5.1% | −14.2% | 5.3% | −2.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in LIVN's financial statements (latest annual report filed February 25, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
LIVN financial results
In fiscal year 2025 (ended December 31, 2025), LivaNova reported revenue of $1.4 billion, up 10.7% from the year before. It had a net loss of $242.5 million, a net profit margin of −17.5%. Diluted earnings per share came to $3.76. Over five years revenue grew at an average rate of 8.2% a year.
See the LIVN stock overview for the latest quote and news, or the LIVN chart for price history and technical indicators.
LIVN income statement FAQ
What is LivaNova's annual revenue?
LivaNova reported total revenue of $1.4 billion for fiscal year 2025, which ended on December 31, 2025. That was up 10.7% from $1.3 billion the previous year.
Is LivaNova profitable?
No. LivaNova reported a net loss of $242.5 million in fiscal 2025, a net profit margin of −17.5%; its operating margin was 14.4%.
What is LivaNova's gross margin?
LivaNova's gross margin was 67.7% in fiscal 2025: for every $100 of revenue, LivaNova kept $68 after the direct cost of its products and services.
How much does LivaNova spend on research and development?
LivaNova spent $185.8 million on research and development in fiscal 2025, 13.4% of revenue.
How fast is LivaNova growing?
Revenue grew 8.2% a year on average over the last five fiscal years, from $934.2 million to $1.4 billion.
What are LivaNova's earnings per share?
LivaNova earned $3.76 per diluted share in fiscal 2025, compared with $3.37 a year earlier.
When will LivaNova report its next earnings?
LivaNova is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens.
When does LivaNova's fiscal year end?
LivaNova's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 25, 2026.